Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immunity Gene Predicts Severe Adverse Drug Reaction

02.04.2004


In a study of Han Chinese patients, researchers have for the first time directly linked a gene of the immune system to a severe adverse drug reaction called Stevens-Johnson syndrome (SJS), according to a Duke University Medical Center medical geneticist and collaborators in Taiwan.



The sometimes fatal condition is characterized by a blistering rash that can lead to detachment of the skin and inflammation of the gastrointestinal and respiratory lining. More than 100 drugs -- including antibiotics, NSAIDS, anticonvulsants and the gout drug allopurinol -- are known to cause SJS in rare cases. The frequency with which particular prescriptions spur the devastating reaction varies among people of different ethnic backgrounds.

Their new test for the predisposing gene could be applied almost immediately to determine which of the 1.2 billion Chinese worldwide would be at risk for the reaction to the popular anti-epilepsy drug carbamazepine (trade name Tegretol), said Y-T Chen, M.D., chief of medical genetics at Duke University Medical Center and director of the Institute of Biomedical Sciences at Academia Sinica in Taiwan. The anticonvulsant is the most common cause of SJS among the Chinese population.


The finding highlights the promise of pharmacogenomics for avoiding drugs’ most serious side effects and might also lead to advances in the clinical trial of new drugs, said the researchers.

A single genetic marker predicted with 100 percent accuracy those who could safely take carbamazepine, the team reported in the April 1, 2004, issue of Nature. Individuals with a particular version of the immunity gene who took the drug suffered the devastating reaction in all but 3 percent of the cases.

Whether the gene variant will predict the drug reaction in people of other ethnic backgrounds remains to be tested, said Chen. However, his team expects that other similar genes will be found to underlie the reaction induced by the many other drugs that have been linked to SJS. Such findings would enable drug-specific genetic screening tests to prevent the condition.

"In the near future, physicians will be able to test patients’ genetic makeup before prescribing medications in order to predict those that are likely to have a severe adverse reaction," Chen said. "The technology is here and there will be more advances to come."

Understanding such genetic interactions might also prove a boon to new drug development, said Chen, noting that some drugs have been eliminated in the clinical trial phase because they produced SJS symptoms in some participants.

In the United States, the condition, which is fatal in 10 percent of cases, occurs in approximately 500 people per year. The condition is four or five times more common in the Chinese population in comparison to the U.S., said Chen. Many more people worldwide are at risk of SJS should they take particular prescription drugs, he added.

Adverse drug reactions stem from two primary causes. In some cases, drug concentrations build to toxic levels due to a person’s genetic inability to metabolize the medication. In others, elements of the immune system mobilize and attack the drug, thereby producing the symptoms.

The investigators screened genetic factors known to play a role in drug metabolism and the immune response in three groups:

-- 44 patients with carbamazepine-induced SJS
-- 101 patients that had taken the drug for three months with no adverse reaction
-- 93 healthy individuals not taking the drug.

All patients with SJS carried the genetic variant human leukocyte antigen B* 1502 (HLA-B* 1502), while only 3 percent of those tolerant of the drug carried that version of the HLA gene, the team found.

HLA markers -- perhaps most familiar for their use in determining suitable matches for bone marrow transplantation -- play a critical role in the immune system’s recognition of foreign invaders, whether infectious agents or foreign substances such as medications, explained Chen.

The team has set out to identify other genetic markers linked to severe adverse reactions to other drugs. They also plan to further examine the precise mechanism underlying the connection between HLA-B* 1502 and carbamazepine-induced SJS.

Collaborators include Wen-Hung Chung, M.D., Hong-Shang Hong, M.D., Hsin-Chun Ho, M.D., Mo-Song Hsih, M.D., and Li-Cheng Yang, M.D., all of Chang Gung Memorial Hospital in Taiwan; Jer-Yuarn Wu, Ph.D.; and Shuen-Iu Hung, Ph.D., of Academia Sinica.

Kendall Morgan | dukemed news
Further information:
http://www.dukemednews.org/news/article.php?id=7501

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>